ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 10.50
-0.40 (-3.67%)
Sep 4, 2026, 1:27 PM CET
ViroGates Balance Sheet
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 17.64 | 26.3 | 12.21 | 16.03 | 9.88 | 14.86 |
Cash & Short-Term Investments | 17.64 | 26.3 | 12.21 | 16.03 | 9.88 | 14.86 |
Cash Growth | 48.47% | 115.41% | -23.83% | 62.25% | -33.52% | -55.68% |
Accounts Receivable | 0.41 | 1.17 | 1.21 | 1.75 | 1.8 | 1.47 |
Other Receivables | 1.72 | 1.06 | 1.07 | 1.37 | 1.83 | 1.77 |
Receivables | 2.13 | 2.23 | 2.28 | 3.13 | 3.63 | 3.24 |
Inventory | 1.45 | 1.75 | 2.81 | 5.14 | 3.77 | 1.7 |
Prepaid Expenses | 0.67 | 0.13 | 0.18 | 0.09 | 0.04 | 0.04 |
Other Current Assets | -0 | -0 | -0 | - | - | -0 |
Total Current Assets | 21.89 | 30.4 | 17.48 | 24.38 | 17.31 | 19.84 |
Property, Plant & Equipment | - | - | - | - | 0.04 | 0.22 |
Other Long-Term Assets | 0.19 | 0.19 | 0.18 | 0.18 | 0.19 | 0.18 |
Total Assets | 22.08 | 30.59 | 17.66 | 24.56 | 17.54 | 20.23 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.95 | 0.63 | 0.28 | 1.56 | 0.57 | 0.38 |
Current Portion of Long-Term Debt | 1.23 | 1.29 | 1.03 | - | - | - |
Other Current Liabilities | 0.99 | 5.93 | 1.28 | 0.69 | 0.88 | 3.42 |
Total Current Liabilities | 3.17 | 7.86 | 2.59 | 2.25 | 1.45 | 3.8 |
Long-Term Debt | 2.7 | 3.33 | 4.27 | 5.3 | - | - |
Other Long-Term Liabilities | - | - | 0 | - | - | - |
Total Liabilities | 5.87 | 11.19 | 6.87 | 7.55 | 1.45 | 3.8 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 9.28 | 9.28 | 7.74 | 6.45 | 3.35 | 3.17 |
Retained Earnings | 6.92 | 10.12 | 3.06 | 10.56 | 12.74 | 13.26 |
Comprehensive Income & Other | - | - | - | -0 | - | - |
Shareholders' Equity | 16.2 | 19.4 | 10.8 | 17.01 | 16.09 | 16.43 |
Total Liabilities & Equity | 22.08 | 30.59 | 17.66 | 24.56 | 17.54 | 20.23 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.93 | 4.62 | 5.3 | 5.3 | - | - |
Net Cash (Debt) | 13.7 | 21.67 | 6.91 | 10.73 | 9.88 | 14.86 |
Net Cash Growth | 100.53% | 213.75% | -35.60% | 8.60% | -33.52% | -55.68% |
Net Cash Per Share | 1.48 | 2.74 | 1.04 | 3.10 | 3.03 | 4.71 |
Filing Date Shares Outstanding | 9.28 | 9.28 | 7.73 | 6.44 | 3.35 | 3.17 |
Total Common Shares Outstanding | 9.28 | 9.28 | 7.73 | 6.44 | 3.35 | 3.17 |
Working Capital | 18.72 | 22.55 | 14.89 | 22.13 | 15.86 | 16.04 |
Book Value Per Share | 1.75 | 2.09 | 1.40 | 2.64 | 4.81 | 5.19 |
Tangible Book Value | 16.2 | 19.4 | 10.8 | 17.01 | 16.09 | 16.43 |
Tangible Book Value Per Share | 1.75 | 2.09 | 1.40 | 2.64 | 4.81 | 5.19 |